BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu M, Shen J. From Super-Enhancer Non-coding RNA to Immune Checkpoint: Frameworks to Functions. Front Oncol 2019;9:1307. [PMID: 31824865 DOI: 10.3389/fonc.2019.01307] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Hu X, Wu L, Yao Y, Ma J, Li X, Shen H, Liu L, Dai H, Wang W, Chu X, Sheng C, Yang M, Zheng H, Song F, Chen K, Liu B. The integrated landscape of eRNA in gastric cancer reveals distinct immune subtypes with prognostic and therapeutic relevance. iScience 2022;25:105075. [PMID: 36157578 DOI: 10.1016/j.isci.2022.105075] [Reference Citation Analysis]
2 Panahi-Moghadam S, Hassani S, Farivar S, Vakhshiteh F. Emerging Role of Enhancer RNAs as Potential Diagnostic and Prognostic Biomarkers in Cancer. Noncoding RNA 2022;8:66. [PMID: 36287118 DOI: 10.3390/ncrna8050066] [Reference Citation Analysis]
3 Napoli S, Munz N, Guidetti F, Bertoni F. Enhancer RNAs (eRNAs) in Cancer: The Jacks of All Trades. Cancers 2022;14:1978. [DOI: 10.3390/cancers14081978] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Zhang RM, Pan Y, Zou CX, An Q, Cheng JR, Li PJ, Zheng ZH, Pan Y, Feng WY, Yang SF, Shi DS, Wei YM, Deng YF. CircUBE2Q2 promotes differentiation of cattle muscle stem cells and is a potential regulatory molecule of skeletal muscle development. BMC Genomics 2022;23:267. [PMID: 35387588 DOI: 10.1186/s12864-022-08518-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Han Z, Li W. Enhancer RNA: What we know and what we can achieve. Cell Prolif 2022;:e13202. [PMID: 35170113 DOI: 10.1111/cpr.13202] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
6 Guo G, Wang H, Tong X, Ye L, Shi X, Fang S, Hu Y, Han F, Chen C, Ding N, Su B, Xue X, Zhang H. Transcriptional Landscape of Enhancer RNAs in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus. JIR 2022;Volume 15:775-91. [DOI: 10.2147/jir.s331188] [Reference Citation Analysis]
7 Belloucif Y, Lobry C. Super-Enhancers Dysregulations in Hematological Malignancies. Cells 2022;11:196. [PMID: 35053311 DOI: 10.3390/cells11020196] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Ye M, Wang S, Qie JB, Sun PL. SPRY4-AS1, A Novel Enhancer RNA, Is a Potential Novel Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma. Front Oncol 2021;11:765484. [PMID: 34671565 DOI: 10.3389/fonc.2021.765484] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Jiang Y, Zhang C, Long L, Ge L, Guo J, Fan Z, Yu G. A Comprehensive Analysis of SE-lncRNA/mRNA Differential Expression Profiles During Chondrogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells. Front Cell Dev Biol 2021;9:721205. [PMID: 34589487 DOI: 10.3389/fcell.2021.721205] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Stasevich EM, Murashko MM, Zinevich LS, Demin DE, Schwartz AM. The Role of Non-Coding RNAs in the Regulation of the Proto-Oncogene MYC in Different Types of Cancer. Biomedicines 2021;9:921. [PMID: 34440124 DOI: 10.3390/biomedicines9080921] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Li GH, Qu Q, Qi TT, Teng XQ, Zhu HH, Wang JJ, Lu Q, Qu J. Super-enhancers: a new frontier for epigenetic modifiers in cancer chemoresistance. J Exp Clin Cancer Res 2021;40:174. [PMID: 34011395 DOI: 10.1186/s13046-021-01974-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
12 Ma J, Lin X, Wang X, Min Q, Wang T, Tang C. Reconstruction and Analysis of the Immune-Related LINC00987/A2M Axis in Lung Adenocarcinoma. Front Mol Biosci 2021;8:644557. [PMID: 33987201 DOI: 10.3389/fmolb.2021.644557] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
13 Yamamoto Y, Miura O, Ohyama T. Cruciform Formable Sequences within Pou5f1 Enhancer Are Indispensable for Mouse ES Cell Integrity. Int J Mol Sci 2021;22:3399. [PMID: 33810223 DOI: 10.3390/ijms22073399] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Kim T. LncRNAs as key players in the MYC pathways. GENOME INSTAB DIS 2021;2:24-38. [DOI: 10.1007/s42764-021-00032-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Arman K, Möröy T. Crosstalk Between MYC and lncRNAs in Hematological Malignancies. Front Oncol 2020;10:579940. [PMID: 33134177 DOI: 10.3389/fonc.2020.579940] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
16 Guay C, Jacovetti C, Bayazit MB, Brozzi F, Rodriguez-Trejo A, Wu K, Regazzi R. Roles of Noncoding RNAs in Islet Biology. Compr Physiol 2020;10:893-932. [PMID: 32941685 DOI: 10.1002/cphy.c190032] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
17 Tan Y, Li Y, Tang F. Oncogenic seRNA functional activation: a novel mechanism of tumorigenesis. Mol Cancer 2020;19:74. [PMID: 32278350 DOI: 10.1186/s12943-020-01195-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
18 Orozco-Solis R, Aguilar-Arnal L. Circadian Regulation of Immunity Through Epigenetic Mechanisms. Front Cell Infect Microbiol 2020;10:96. [PMID: 32232012 DOI: 10.3389/fcimb.2020.00096] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 13.5] [Reference Citation Analysis]